azacitidine has been researched along with Li-Fraumeni Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, J; Fridman, AL; Kulaeva, OI; Land, SJ; Li, Q; Nahhas, F; Roberts, PC; Tainsky, MA; Tang, L; Ye, B | 1 |
Fridman, AL; Li, Q; Rosati, R; Tainsky, MA | 1 |
Christiansen-Weber, T; Haas, M; Haggblom, C; Vogt, M; Yeargin, J | 1 |
3 other study(ies) available for azacitidine and Li-Fraumeni Syndrome
Article | Year |
---|---|
Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.
Topics: Azacitidine; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Cytoskeleton; Decitabine; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Fibroblasts; Gene Expression Profiling; Genes, p53; Humans; Interferon Regulatory Factor-7; Interferon-alpha; Interferon-beta; Li-Fraumeni Syndrome; Male; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2006 |
Epigenetic and functional analysis of IGFBP3 and IGFBPrP1 in cellular immortalization.
Topics: Azacitidine; Blotting, Western; Cell Division; Cell Line, Transformed; Cell Proliferation; Cell Transformation, Neoplastic; Cluster Analysis; Decitabine; Epigenesis, Genetic; Gene Expression; Gene Expression Profiling; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Interferon-alpha; Li-Fraumeni Syndrome; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |
Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts.
Topics: 5-Methylcytosine; Azacitidine; Cell Division; Cell Line, Transformed; Cellular Senescence; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Decitabine; DNA Methylation; DNA, Complementary; Gene Expression Regulation; Genes, p16; Genes, p53; Germ-Line Mutation; Humans; Li-Fraumeni Syndrome | 1998 |